Brief: Aerovate Therapeutics Announces First Quarter Financial Results And Business Highlights
15/05/2023 21:40
Aerovate Therapeutics Inc AVTE.O :
* AEROVATE THERAPEUTICS ANNOUNCES FIRST QUARTER FINANCIAL
RESULTS
AND BUSINESS HIGHLIGHTS
* AEROVATE THERAPEUTICS INC - SUFFICIENTLY FUNDED INTO
SECOND HALF
OF 2025
* AEROVATE THERAPEUTICS INC QTRLY LOSS PER SHARE $0.67
Source text for Eikon: ID:nGNX85SLKS
Further company coverage: AVTE.O
Recent news on Jade Biosciences
See all newsBrief: Jade Biosciences Announces Preclinical Data Characterizing Jade301, A Potentially Best-In-Class, Half-Life-Extended Anti-Ifn-Β Monoclonal Antibody In Development For Dermatomyositis, At Eadv 2026
U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage
Jade Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Jade Biosciences Q2 net loss widens as costs rise
Brief: Jade Biosciences, Inc Q2 Cash & Investments USD 461.2 Million